B GROUP, INC.

PrivateCIK: 2043476
Location

DALLAS, TX

πŸ“‹ What this filing means

B GROUP, INC. filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $116.73M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

19
Positions
$116.73M
Total AUM (reported)
11.20M
Total Shares

Allocation by class

TOTAL AUM$116.73M19 positions
COM$69.69M59.7%
COM PAR $.01$20.03M17.2%
ADR$14.46M12.4%
SPON ADS$4.04M3.5%
COM NEW$3.76M3.2%
COM SHS$1.75M1.5%
SPONSORED ADS$1.37M1.2%

Portfolio Concentration

Top 368.9%4–1023.4%11–257.7%TOP 1092.3%0%100%
Top 3$80.46M68.9%
4–10$27.28M23.4%
11–25$9.00M7.7%

Top 3 weight

68.9%

Top 10 weight

92.3%

Voting Authority Distribution

Total shares with voting rights: 11.20M

Sole

Full voting authority

11.20M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole19
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings19
Rows:

ADMA BIOLOGICS INC

SOLE
COM
Shares2.32M
TypeSH
Market value$45.98M
39.39%
Sole
2.32M
Shared
0.00
None
0.00

INSMED INC

SOLE
COM PAR $.01
Shares262.50K
TypeSH
Market value$20.03M
17.16%
Sole
262.50K
Shared
0.00
None
0.00

ZAI LAB LTD

SOLE
ADR
Shares400K
TypeSH
Market value$14.46M
12.38%
Sole
400K
Shared
0.00
None
0.00

AKERO THERAPEUTICS INC

SOLE
COM
Shares242.50K
TypeSH
Market value$9.82M
8.41%
Sole
242.50K
Shared
0.00
None
0.00

IOVANCE BIOTHERAPEUTICS INC

SOLE
COM
Shares1.50M
TypeSH
Market value$5.00M
4.28%
Sole
1.50M
Shared
0.00
None
0.00

CELLECTIS S A

SOLE
SPON ADS
Shares3.26M
TypeSH
Market value$4.04M
3.46%
Sole
3.26M
Shared
0.00
None
0.00

AURA BIOSCIENCES INC

SOLE
COM
Shares472.58K
TypeSH
Market value$2.77M
2.37%
Sole
472.58K
Shared
0.00
None
0.00

SIGHT SCIENCES INC

SOLE
COM
Shares833.60K
TypeSH
Market value$2.00M
1.71%
Sole
833.60K
Shared
0.00
None
0.00

ASSEMBLY BIOSCIENCES INC

SOLE
COM NEW
Shares200K
TypeSH
Market value$1.91M
1.64%
Sole
200K
Shared
0.00
None
0.00

TAYSHA GENE THERAPIES INC

SOLE
COM SHS
Shares1.26M
TypeSH
Market value$1.75M
1.50%
Sole
1.26M
Shared
0.00
None
0.00

ULTRAGENYX PHARMACEUTICAL IN

SOLE
COM
Shares47.50K
TypeSH
Market value$1.72M
1.47%
Sole
47.50K
Shared
0.00
None
0.00

BIONTECH SE

SOLE
SPONSORED ADS
Shares15K
TypeSH
Market value$1.37M
1.17%
Sole
15K
Shared
0.00
None
0.00

ULTRAGENYX PHARMACEUTICAL IN

SOLE
CALL
Shares37.60K
TypeSH
Market value$1.36M
1.17%
Sole
37.60K
Shared
0.00
None
0.00

SPYRE THERAPEUTICS INC

SOLE
COM NEW
Shares70K
TypeSH
Market value$1.13M
0.97%
Sole
70K
Shared
0.00
None
0.00

APOGEE THERAPEUTICS INC

SOLE
COM
Shares30K
TypeSH
Market value$1.12M
0.96%
Sole
30K
Shared
0.00
None
0.00

PRAXIS PRECISION MEDICINES I

SOLE
COM NEW
Shares19K
TypeSH
Market value$719.5K
0.62%
Sole
19K
Shared
0.00
None
0.00

89BIO INC

SOLE
COM
Shares95.62K
TypeSH
Market value$695.2K
0.60%
Sole
95.62K
Shared
0.00
None
0.00

ORUKA THERAPEUTICS INC

SOLE
COM
Shares58.22K
TypeSH
Market value$597.3K
0.51%
Sole
58.22K
Shared
0.00
None
0.00

CORVUS PHARMACEUTICALS INC

SOLE
PUT
Shares90K
TypeSH
Market value$286.2K
0.25%
Sole
90K
Shared
0.00
None
0.00
B GROUP, INC. 13F Holdings β€” 19 Positions | Finecho